CANVAC JUNIOR
Selected mammalians
1.0 ml s. c.
Product characteristics
The product CANVAC JUNIOR is a bivalent vaccine against distemper and parvovirosis of dogs.
Dosage form
An injectable solution for parenteral administration which originates when the lyophilized constituent of the live vaccine against distemper is reconstituted in the liquid constituent of an inactivated ingredient of parvovirosis of dogs.
Qualitative and quantitative composition
Each one vaccination dose of the product contains:
Active ingredients:
virus febris contagiosae canis attenuatum at an amount min. 104,0 - 104,5 EID50;
parvovirus enteritidis canis inactivatum at an amount of 1024 - 2048 HAU
Inactive ingredients:
algeldratum 2,0 mg.ml-1;
thiomersalum 0,010%;
aqua pro injectione ad 1ml.
Animal species to be treated with the product Dogs, canine and musteline animals and fur-coat animals
Dosage
A dose per 1 animal is 1.0 ml irrespective of animal species and weight.
Overdosage
In case of the live valence, the vaccine is safe even when a ten-fold dose is used, while in case of
the inactivated valence, a doubled dose of the vaccine is safe.
Route of administration
Reconstitute the lyophilizate of the vaccine in the liquid constituent of the product immediately prior to use. Before use, the contents of the medicinal bottle must be thoroughly dissolved. The vaccine should be administered subcutaneously, best of all at the area behind the scapula.
The vaccination schedule must be defi ned by the veterinary surgeon. When youngsters are to be vaccinated, the level of immunity of mothers must be taken into account (i.e. whether or not mothers have been immunized). It is advisable to revaccinate the vaccinated animals younger than 4 months (approximately over two to three weeks). In order to minimize an undesirable infl uence of the colostral immunity in pups, animals may be re-vaccinated repeatedly at three-week intervals. For the maintenance of lasting immunity, an annual revaccination on a regular basis is recommended.
Indications
The vaccine is designed for the active immunization of dogs, canine and musteline animals and fur-coat animals against distemper and parvovirosis of dogs.
Contraindications
Vaccination represents a general immunobiological stress for an animal being immunized, and hence it should be used in healthy animals only. Therefore, it is contraindicated particularly in
the following cases:
- acute infectious diseases,
- organ and feverish diseases, and in cases when an adverse post-vaccination reaction or
allergy to former vaccinations were ascertained in animals,
- after a stress to which animals were exposed (transportation, high temperatures of the
environment).
The vaccine must not be used in cases of running infections against which the vaccine is designed, and it must not be administered simultaneously with passive immunization of animals, i.e. on parenteral administration of specifi c antibodies.
Adverse drug reactions
Infrequently, the administration of the vaccine may induce a slight sub-febrile increase in temperature and transient inappetence; in rare cases, after a previous sensitization, an anaphylactic reactions may occur. Within fi ve days, a solid/elastic formation, sized a pea, may originate at the site of administration of the vaccine. Its spontaneous disappearance is recorded within 20 days after administration of the vaccine. The formation originates as a temporary local reaction to the adjuvant constituent of the vaccine.
Interactions
None.
Pregnancy and lactation
The product is designed for young animals.
Withdrawal periods
None. The vaccine is environmentally friendly.
How supplied
Type of package:
Glass or plastic medicinal bottles are closed with a rubber stopper and an aluminum torque collar, provided with a label and placed in a carton box together with a package information
leaflet.
Package Availability
1.0 ml of the lyophilized suspension in a 3-ml medicinal bottle;
1.0 ml of the diluent in a 3-ml medicinal bottle,
i.e. 1 dose.
6 doses, i.e. 6 medicinal bottles of the lyophilized constituent and 6 medicinal bottles of the diluent, are placed in 1 carton box.
Shelf-life
The product must be completely used until expiration of the shelf-life indicated on the label of each medicinal bottle, i.e. within 18 months from the date of manufacture. The product must not be used after expiration of the shelf-life. The vaccine must be used completely immediately after its reconstitution.
Storage
In a dry and dark place, at temperatures between 2 and 8 °C
Special precautions
The route of vaccination and the vaccination schedule in fur-coat animals depend on a decision made by the veterinary surgeon. In very rare cases, fur-coat animals may produce a generally adverse reaction to live valences of the vaccine. If ferrets are to be vaccinated, higher caution is necessary after administration of the vaccine owing to enhanced susceptibility of this animal species to the attenuated virus of distemper. After vaccination, it is advisable to leave animals at rest for 2 to 3 days. It is especially recommended to avoid training, hunting or other strenuous activities in dogs. It is also recommended to avoid shifting of animals or their exposure to stress conditions. Youngsters should be left at rest for approximately 1 week.
It is recommended to immunize de-wormed animals.
It is not recommended to immunize youngsters after birth and very young animals owing to an incomplete and developing immunocompetence and potential adverse effects of the specifi c colostral immunity.
1.0 ml s. c.
Product characteristics
The product CANVAC JUNIOR is a bivalent vaccine against distemper and parvovirosis of dogs.
Dosage form
An injectable solution for parenteral administration which originates when the lyophilized constituent of the live vaccine against distemper is reconstituted in the liquid constituent of an inactivated ingredient of parvovirosis of dogs.
Qualitative and quantitative composition
Each one vaccination dose of the product contains:
Active ingredients:
virus febris contagiosae canis attenuatum at an amount min. 104,0 - 104,5 EID50;
parvovirus enteritidis canis inactivatum at an amount of 1024 - 2048 HAU
Inactive ingredients:
algeldratum 2,0 mg.ml-1;
thiomersalum 0,010%;
aqua pro injectione ad 1ml.
Animal species to be treated with the product Dogs, canine and musteline animals and fur-coat animals
Dosage
A dose per 1 animal is 1.0 ml irrespective of animal species and weight.
Overdosage
In case of the live valence, the vaccine is safe even when a ten-fold dose is used, while in case of
the inactivated valence, a doubled dose of the vaccine is safe.
Route of administration
Reconstitute the lyophilizate of the vaccine in the liquid constituent of the product immediately prior to use. Before use, the contents of the medicinal bottle must be thoroughly dissolved. The vaccine should be administered subcutaneously, best of all at the area behind the scapula.
The vaccination schedule must be defi ned by the veterinary surgeon. When youngsters are to be vaccinated, the level of immunity of mothers must be taken into account (i.e. whether or not mothers have been immunized). It is advisable to revaccinate the vaccinated animals younger than 4 months (approximately over two to three weeks). In order to minimize an undesirable infl uence of the colostral immunity in pups, animals may be re-vaccinated repeatedly at three-week intervals. For the maintenance of lasting immunity, an annual revaccination on a regular basis is recommended.
Indications
The vaccine is designed for the active immunization of dogs, canine and musteline animals and fur-coat animals against distemper and parvovirosis of dogs.
Contraindications
Vaccination represents a general immunobiological stress for an animal being immunized, and hence it should be used in healthy animals only. Therefore, it is contraindicated particularly in
the following cases:
- acute infectious diseases,
- organ and feverish diseases, and in cases when an adverse post-vaccination reaction or
allergy to former vaccinations were ascertained in animals,
- after a stress to which animals were exposed (transportation, high temperatures of the
environment).
The vaccine must not be used in cases of running infections against which the vaccine is designed, and it must not be administered simultaneously with passive immunization of animals, i.e. on parenteral administration of specifi c antibodies.
Adverse drug reactions
Infrequently, the administration of the vaccine may induce a slight sub-febrile increase in temperature and transient inappetence; in rare cases, after a previous sensitization, an anaphylactic reactions may occur. Within fi ve days, a solid/elastic formation, sized a pea, may originate at the site of administration of the vaccine. Its spontaneous disappearance is recorded within 20 days after administration of the vaccine. The formation originates as a temporary local reaction to the adjuvant constituent of the vaccine.
Interactions
None.
Pregnancy and lactation
The product is designed for young animals.
Withdrawal periods
None. The vaccine is environmentally friendly.
How supplied
Type of package:
Glass or plastic medicinal bottles are closed with a rubber stopper and an aluminum torque collar, provided with a label and placed in a carton box together with a package information
leaflet.
Package Availability
1.0 ml of the lyophilized suspension in a 3-ml medicinal bottle;
1.0 ml of the diluent in a 3-ml medicinal bottle,
i.e. 1 dose.
6 doses, i.e. 6 medicinal bottles of the lyophilized constituent and 6 medicinal bottles of the diluent, are placed in 1 carton box.
Shelf-life
The product must be completely used until expiration of the shelf-life indicated on the label of each medicinal bottle, i.e. within 18 months from the date of manufacture. The product must not be used after expiration of the shelf-life. The vaccine must be used completely immediately after its reconstitution.
Storage
In a dry and dark place, at temperatures between 2 and 8 °C
Special precautions
The route of vaccination and the vaccination schedule in fur-coat animals depend on a decision made by the veterinary surgeon. In very rare cases, fur-coat animals may produce a generally adverse reaction to live valences of the vaccine. If ferrets are to be vaccinated, higher caution is necessary after administration of the vaccine owing to enhanced susceptibility of this animal species to the attenuated virus of distemper. After vaccination, it is advisable to leave animals at rest for 2 to 3 days. It is especially recommended to avoid training, hunting or other strenuous activities in dogs. It is also recommended to avoid shifting of animals or their exposure to stress conditions. Youngsters should be left at rest for approximately 1 week.
It is recommended to immunize de-wormed animals.
It is not recommended to immunize youngsters after birth and very young animals owing to an incomplete and developing immunocompetence and potential adverse effects of the specifi c colostral immunity.
